EUVIMEDEUVIMED entdecken
Crossref

Friend or foe? IFNλ drives fibrosis

Ivan Zanoni iD

Journal of Experimental Medicine · 03.08.2026 · 223 (8)

DOI: 10.1084/jem.20260881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 06.07.2026. Verfasst von Ivan Zanoni. Beteiligte Einrichtung: Harvard Medical School, Boston Children's Hospital , Boston, MA, USA. Hauptthemen laut MEDLINE: Interferons, Kidney. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type III IFNs, or IFNλ, are pleiotropic immune mediators that mostly work at mucosal surfaces by signaling in epithelial cells and selected immune cells. Zhou, Zhang, and colleagues (https://doi.org/10.1084/jem.20251858) demonstrate that IFNλ also signals in kidney fibroblasts sustaining renal fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InterferonsKidneyHumansAnimalsFibrosisSignal TransductionFibroblastsInterferon Lambda

Substanzen

InterferonsInterferon Lambda

Autor:innen und Institutionen

  • Harvard Medical School, Boston Children's Hospital , Boston, MA, USA.

ORCID-Profile: Ivan Zanoni

Zitieren

APA

Zanoni, I. (2026). Friend or foe? IFNλ drives fibrosis. Journal of Experimental Medicine, 223(8). https://doi.org/10.1084/jem.20260881

Vancouver

Zanoni I. Friend or foe? IFNλ drives fibrosis. Journal of Experimental Medicine. 2026;223(8). doi:10.1084/jem.20260881

BibTeX
@article{Zanoni2026,
  author = {Zanoni, Ivan},
  title = {Friend or foe? IFNλ drives fibrosis},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  volume = {223},
  number = {8},
  doi = {10.1084/jem.20260881}
}
Kostenlos starten →